Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 18,156
Companies: 1,062
Drugs tracked: 3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

Miricorilant (Cohort A)

Miricorlilant

Nenocorilant 200 mg

Relacorilant

Relacorilant 150 mg once daily (QD)

Relacorilant 150 mg once daily (QD)

Relacorilant with nab-paclitaxel

14C-CORT125281

CORT113176

CORT113176 Lipid Capsule Formulation

CORT118335 Oral

CORT118335, 25 mg

CORT125134

CORT125134 150 mg

CORT125236

CORT125281, 40mg, fasted

CORT125329 lipid capsule formulation

Dabigatran Etexilate

Dazucorilant

Dazucorilant

Enzalutamide

Midazolam hydrochloride

Mifepristone

Mifepristone 300 MG

Frequently asked questions